Unichem Laboratories shares experienced a dramatic surge of 17.79% to ₹598.35 per share on Tuesday following the release of strong Q1 FY27 results. According to reports from Essential Business Intelligence, the stock opened at ₹510.05 compared with its previous close of ₹507.15, and surged to an intraday high of ₹600, representing a gain of more than 18% from the previous closing price. The stock touched an intraday low of ₹501.25 and has demonstrated strong momentum with 50% gains over three months and 15% returns in one year, though it has declined 11% in the past month. As of 1:55 PM, trading volume stood at 10,12,308 shares with the stock trading in a range of ₹501.25 to ₹600.
The pharmaceutical company achieved a remarkable financial turnaround in Q1 FY27, posting a consolidated net profit of ₹41.47 crore compared to a net loss of ₹10.47 crore in the corresponding quarter of the previous year. As reported by Essential Business Intelligence and Business Standard, this represents a significant improvement from the net profit of ₹10.91 crore recorded in the March quarter. The company's profit before exceptional items and tax stood at ₹48.99 crore during the June quarter, compared with a loss of ₹9.02 crore in the corresponding period last year. The June quarter did not include any exceptional item, unlike the March quarter which had included an exceptional charge of ₹12.36 crore.
Revenue from operations showed robust growth, rising 20.13% year-on-year to ₹632.62 crore from ₹526.60 crore in the same quarter last year. According to the company's Q1 FY27 results reported by Business Standard, this substantial revenue increase indicates strong market demand and successful business expansion strategies. The company's cost of materials consumed declined to ₹190.02 crore from ₹217.48 crore year-on-year, even as revenue increased during the period, demonstrating improved cost management. Employee benefit expenses also declined to ₹103.31 crore, compared with ₹107.42 crore in the year-ago quarter, further contributing to the improved profitability metrics.
The company's operational performance showed remarkable improvement with EBITDA increasing to ₹69.6 crore from ₹22.5 crore year-on-year, representing a substantial increase in operational efficiency. As reported by Essential Business Intelligence and Business Standard, the EBITDA margin expanded significantly to 11% from 4.3% in the corresponding quarter last year. This margin expansion demonstrates the company's ability to enhance profitability through better cost management and operational optimization strategies. The sequential improvement is particularly notable, with net profit increasing from ₹10.91 crore in the March quarter to ₹41.47 crore in the June quarter, alongside an improvement in operating margin. The company's PBDT (Profit Before Depreciation and Tax) surged 247% to ₹78.93 crore from ₹22.77 crore in the previous year, indicating strong operational leverage.
